Results 221 to 230 of about 3,035,557 (301)

Catastrophic Antiphospholipid Syndrome: When STEMI Is Not Atherosclerotic. [PDF]

JACC Case Rep
Choudhury SH, Wexler A, Shah M, Farooq S, McGrody KS.   +4 more
europepmc   +1 more source

Does the teicoplanin skin test predict IgE-mediated hypersensitivity? [PDF]

Allergol Select
Baştuğ İnan NB, Göktürk Ö, Karahan Y, Aksu K.   +3 more
europepmc   +1 more source

Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis

European Journal of Neurology, Volume 33, Issue 6, June 2026.
In this prospective cohort study, Erenumab and OnabotulinumtoxinA showed similar reductions in headache frequency at 3 and 6 months. Both improved quality of life, while Erenumab achieved greater reductions in migraine‐related disability (MIDAS). These findings support individualized treatment selection.
María Garcés‐Pellejero, Marta Torres‐Ferrús, Rut Mas‐de‐les‐Valls, Edoardo Caronna, Alicia Alpuente, Eulalia Giné‐Ciprés, Patricia Pozo‐Rosich   +6 more
wiley   +1 more source

Allergic Anisakiasis: An Integrated Review of Human, Animal and Cellular Evidence. [PDF]

Biomolecules
Isola S, Zumbo E, Dimasi F, Minciullo PL, Gangemi S.   +4 more
europepmc   +1 more source

Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis

International Journal of Dermatology, Volume 65, Issue 6, Page 1185-1194, June 2026.
ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao, Litao Zhang, Liming Wu, Bin Yang, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chao Ji, Jing Sun, Yanping Qiu, Bo Chen, Jianzhong Zhang   +26 more
wiley   +1 more source

Recall urticaria caused by vedolizumab: case report and literature review. [PDF]

Front Allergy
Kozuma M, Hara R, Sakuragi Y, Saito-Sasaki N, Sawada Y.   +4 more
europepmc   +1 more source

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care. [PDF]

Biomedicines
Topa E, Cristallo M, Rizzi A, Lamacchia D, Gamberale S, Caruso C, Rossi O, Di Leo E, Bova M, Nettis E.   +9 more
europepmc   +1 more source

A Rare Case of Yellow Urticaria Developing During Blood Transfusion. [PDF]

Cureus
Alsemairi LT, Ahmed A, Ibrahim AI, Zaytuni M, Aljohani KH.   +4 more
europepmc   +1 more source

Severe anaphylactic shock reaction upon rituximab rechallenge in membranous nephropathy: a case report and literature review. [PDF]

Front Pharmacol
Huang W, Xu Y, Jin X, Zhang Q, Xiang T, Lei W.   +5 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source